Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Spirulina compound may shield cancer patients from chemo nerve pain

NCT ID NCT05025826

First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 24 times

Summary

This study tests whether phycocyanin, a natural antioxidant from spirulina, can reduce nerve damage caused by oxaliplatin chemotherapy in people with metastatic gastrointestinal cancers. About 110 participants will receive either phycocyanin or a placebo during their treatment. The goal is to see if the supplement lowers the risk of moderate-to-severe nerve toxicity after four months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC GASTRIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Hospitalier de Cholet

    Cholet, 49300, France

  • Chd La Roche Sur Yon

    La Roche-sur-Yon, France

  • Clermont-Ferrand UH

    Clermont-Ferrand, France, France

  • Foch Suresnes Hosptial

    Suresnes, France

  • Hôpital le Confluent

    Nantes, 44000, France

  • Mutaliste Clinic Saint Nazaire

    Saint-Nazaire, France

  • Nantes Uh

    Nantes, France

  • Saint Gregoire Clinique

    Rennes, France

Conditions

Explore the condition pages connected to this study.